These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 22269856)

  • 1. Prevalence of antibiotic resistance in fecal flora of patients undergoing transrectal ultrasound-guided prostate biopsy in Thailand.
    Siriboon S; Tiengrim S; Taweemongkongsup T; Thamlikitkul V; Chayakulkeeree M
    Urol Int; 2012; 88(2):187-93. PubMed ID: 22269856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ciprofloxacin resistance in the faecal carriage of patients undergoing transrectal ultrasound guided prostate biopsy.
    Taylor S; Margolick J; Abughosh Z; Goldenberg SL; Lange D; Bowie WR; Bell R; Roscoe D; Machan L; Black P
    BJU Int; 2013 May; 111(6):946-53. PubMed ID: 23464844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of fluoroquinolone-resistant rectal flora in patients undergoing transrectal ultrasound-guided prostate needle biopsy: A prospective multicenter study.
    Chung HS; Hwang EC; Yu HS; Jung SI; Lee SJ; Lim DH; Cho WJ; Choe HS; Lee SJ; Park SW
    Int J Urol; 2018 Mar; 25(3):278-283. PubMed ID: 29241300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and characteristics of fecal antimicrobial-resistant Escherichia coli in a cohort of Japanese men undergoing prostate biopsy.
    Kamei J; Yagihara Y; Kume H; Horiuchi T; Sato T; Nakagawa T; Fujimura T; Fukuhara H; Moriya K; Homma Y
    Int J Urol; 2017 Apr; 24(4):295-300. PubMed ID: 28222483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trial Comparing a Combined Regimen of Amikacin and Ciprofloxacin to Ciprofloxacin Alone as Transrectal Prostate Biopsy Prophylaxis in the Era of High Fluoroquinolone-Resistant Rectal Flora.
    Son KC; Chung HS; Jung SI; Kim MS; Hwang EC; Kim JW; Kwon DD
    J Korean Med Sci; 2018 Apr; 33(15):e113. PubMed ID: 29629517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increasing risk of infectious complications after transrectal ultrasound-guided prostate biopsies: time to reassess antimicrobial prophylaxis?
    Carignan A; Roussy JF; Lapointe V; Valiquette L; Sabbagh R; Pépin J
    Eur Urol; 2012 Sep; 62(3):453-9. PubMed ID: 22575912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extended-spectrum β-lactamase in the rectal flora of patients undergoing transrectal prostate biopsy: a study of the prevalence in a major metropolitan hospital.
    Sewell J; Chow K; De Sousa A; Sapre N; Norris B; Namdarian B; Sinickas V; Huang JG; Anderson P
    BJU Int; 2019 May; 123 Suppl 5():43-46. PubMed ID: 31012990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of ciprofloxacin resistant Escherichia coli isolates among men undergoing evaluation for transrectal ultrasound guided prostate biopsy.
    Qi C; Malczynski M; Schaeffer AJ; Barajas G; Nadler RB; Scheetz MH; Zembower TR
    J Urol; 2013 Dec; 190(6):2026-32. PubMed ID: 23727416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rectal cultures before transrectal ultrasound-guided prostate biopsy reduce post-prostatic biopsy infection rates.
    Duplessis CA; Bavaro M; Simons MP; Marguet C; Santomauro M; Auge B; Collard DA; Fierer J; Lesperance J
    Urology; 2012 Mar; 79(3):556-61. PubMed ID: 22386395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Single and Prolonged Fluoroquinolone Prophylaxis and Risk Factors for Infectious Complications After Transrectal Prostate Biopsy.
    Kalkanlı A; Gezmiş CT; Özkan A; Çilesiz NC; Yanaral F; Aydın M; Tandoğdu Z
    Balkan Med J; 2018 Sep; 35(5):373-377. PubMed ID: 29866640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective assessment of the efficacy of single dose versus traditional 3-day antimicrobial prophylaxis in 12-core transrectal prostate biopsy.
    Cam K; Kayikci A; Akman Y; Erol A
    Int J Urol; 2008 Oct; 15(11):997-1001. PubMed ID: 18721198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibiotic susceptibility of intestinal Escherichia coli in men undergoing transrectal prostate biopsies: a prospective, registered, multicentre study.
    Knaapila J; Kallio H; Hakanen AJ; Syvänen K; Ettala O; Kähkönen E; Lamminen T; Seppänen M; Jambor I; Rannikko A; Riikonen J; Munukka E; Eerola E; Gunell M; Boström PJ
    BJU Int; 2018 Aug; 122(2):203-210. PubMed ID: 29533507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibiotic prophylaxis with intravenous ceftriaxone and fluoroquinolone reduces infectious complications after transrectal ultrasound-guided prostatic biopsy.
    Lee C; You D; Jeong IG; Hong JH; Choo MS; Ahn H; Ahn TY; Kim CS
    Korean J Urol; 2015 Jun; 56(6):466-72. PubMed ID: 26078845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of ciprofloxacin-resistant Enterobacteriaceae in the intestinal flora of patients undergoing transrectal prostate biopsy in Norwich, UK.
    Hanna MY; Tremlett C; Josan G; Eltom A; Mills R; Rochester M; Livermore DM
    BJU Int; 2015 Jul; 116(1):131-4. PubMed ID: 25079680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rectal Culture-Guided Targeted Antimicrobial Prophylaxis Reduces the Incidence of Post-Operative Infectious Complications in Men at High Risk for Infections Submitted to Transrectal Ultrasound Prostate Biopsy - Results of a Cross-Sectional Study.
    Boeri L; Fontana M; Gallioli A; Zanetti SP; Catellani M; Longo F; Mangiarotti B; Montanari E
    PLoS One; 2017; 12(1):e0170319. PubMed ID: 28122053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of antibiotic resistance in fecal flora before transrectal ultrasound-guided prostate biopsy and the clinical impact of targeted antibiotic prophylaxis.
    Ozgur A; Asif Y; Gokhan A; Berrin T; Cenk G; Bulent E; Onur D; Meftun C; Haluk V; Hulya C; Turhan C
    Arch Esp Urol; 2017 Dec; 70(10):852-858. PubMed ID: 29205165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluoroquinolone-resistant Escherichia coli among the rectal flora is the predominant risk factor for severe infection after transrectal ultrasound-guided prostate biopsy: a prospective observational study.
    Holmbom M; Forsberg J; Fredrikson M; Nilsson M; Nilsson LE; Hanberger H; Hällgren A
    Scand J Urol; 2023 Aug; 58():32-37. PubMed ID: 37553957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes of fecal carriage of extended-spectrum β-lactamase after transrectal ultrasound-guided biopsy of the prostate.
    Tukenmez Tigen E; Tandogdu Z; Ergonul O; Altinkanat G; Gunaydin B; Ozgen M; Sariguzel N; Erturk Sengel B; Odabasi Z; Cek M; Tokuc R; Turkeri L; Mulazimoglu L; Korten V
    Urology; 2014 Nov; 84(5):1008-15. PubMed ID: 25239255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of antimicrobial resistance in intestinal flora of patients undergoing prostatic biopsy: implications for prophylaxis and treatment of infections after biopsy.
    Batura D; Rao GG; Nielsen PB
    BJU Int; 2010 Oct; 106(7):1017-20. PubMed ID: 20346055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Role of Ciprofloxacin Resistance and Extended-spectrum beta-lactamase (ESBL) Positivity in Infective Complications Following Prostate Biopsy.
    Korkmaz N; Gurbuz Y; Sandikci F; Kul G; Tutuncu EE; Sencan I
    Urol J; 2020 Mar; 17(2):192-197. PubMed ID: 31364100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.